The CEO chose to drop a throwaway line at the end of her presentation to potential investors as reported by Antibotter ie “ Starpharma are pursuing registration in China for Viraleze “ as one of if not the biggest market in the world one would think this is a price sensitive comment after all it was said as bait to potential investors. By not including this in the released presentation slides and not announcing it to the ASX I believe the CEO has not fulfilled her continuous disclosure commitments to the market and shareholders. They could claim that it says seeking to register in new market's is included but thats nonsense she specifically said China to lure investors. I believe there should be an announcement to that effect with details on when and how registrations have been lodged and whether and who possible partners are assisting with the application, if no announcement is forthcoming I believe this transgression should be reported to the ASX, she must be held to account imo
SPL Price at posting:
35.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)